Lung Cancer
Latest News
ICIs for NSCLC: Patients with ILD show greater risk
Clinicians need to ask themselves if there are any alternative therapies that might work just as well if not better than ICI therapy for patients...
Latest News
Monotherapy or one-two punch against EGFR-mutant NSCLC?
Clinicians debate whether combining other drugs with osimertinib adds anything but toxicity to the care of patients with EGFR-mutated NSCLC.
Latest News
Expert views diverge on adding chemotherapy to EGFR TKIs in EGFR-mutant NSCLC
Two physicians weigh the pros and cons of monotherapy over combination therapy for non–small cell lung cancer.
Latest News
Abraxane still in short supply for cancer patients
Allotments for this chemotherapy drug are waning but patients are willing to travel for treatment.
News
U.S. cancer deaths continue to fall, especially lung cancer
There has been an overall decline of 32% in cancer deaths as of 2019.
Latest News
Lung cancer risk misperceptions impede lifesaving screenings
More intensive, repeated, and wide-reaching outreach efforts may be necessary to encourage more high-risk men and women to undergo lung cancer...
Latest News
NSCLC therapies associated with cardiac events
Several targeted NSCLC therapies are strongly associated with cardiac adverse events, such as conduction disease, QT prolongation, and heart...
Latest News
Earlier lung cancer detection may drive lower mortality
Few eligible patients undergo CT screening despite survival benefits.
Latest News
Doctors as trusted messengers
Oncologists are increasingly stepping up for a new role on the front lines of battling cancer-causing air pollution. A new ProPublica report...
Article
Not All Pulmonary Nodules in Smokers are Lung Cancer
Diagnosis of pulmonary nodules requires an in-depth workup, including clinical evaluation, laboratory and pulmonary functions tests, and imaging,...
